Shutting Down the ‘Language Encoder’: A Pathogen‐Derived Nano‐Interferer Disrupt Sialylation Metabolism and Reprogram Intercellular Communication in Glioblastoma

J Jingyi Zhou Z Zonghua Tian (Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China) Y Yun Chen Z Zhenhao Zhao (Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China) X Xuwen Li H Haolin Song (School of Science, Hangzhou Dianzi University , Hangzhou 310018,) H Hongrui Fan (Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China) Y Yuxing Wu (Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China) D Dongxu Wu (Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China) S Shuo Geng (Virginia Tech, Blacksburg, Virginia, United States) Y Yuchen Liu T Tao Sun C Chen Jiang

Abstract

Abstract Glioblastoma (GBM), constrained by the limited cranial space and the blood–brain barrier (BBB), establishes a rapidly adaptable, generalized communication network through enhanced terminal sialylation of membrane proteins. This metabolism‐driven network encodes cellular metabolic states into functional information at the membrane level, thereby markedly enhancing signaling plasticity, intercellular communication, and immune evasion, which together sustain and expand malignant phenotypes within a resource‐limited microenvironment. Here, a “metabolism‐guided decoding of communication architecture” strategy is proposed and developed a brain‐targeted pathogen‐derived nano‐interferer (OMV@HM‐T/F). By simultaneously inhibiting glycosylation precursor synthesis and sialic acid activation, the platform remodels membrane glycan structures, disrupts glycan‐dependent communication scaffolds, and effectively blocks downstream signal amplification and immune suppression pathways. Integrating BBB penetrability with tumor microenvironment responsiveness, this strategy enables precise metabolic‐level intervention, offering a promising approach to overcoming high adaptability and therapeutic resistance.

Article Details

Volume / Issue Vol. 38, Issue 8
Published February 01, 2026
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (13)

J

Jingyi Zhou

Z

Zonghua Tian

Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China

Y

Yun Chen

Z

Zhenhao Zhao

Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China

X

Xuwen Li

H

Haolin Song

School of Science, Hangzhou Dianzi University , Hangzhou 310018,

H

Hongrui Fan

Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China

Y

Yuxing Wu

Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China

D

Dongxu Wu

Department of Pharmaceutics School of Pharmaceutical Sciences Fudan University Key Laboratory of Smart Drug Delivery Ministry of Education State Key Laboratory of Brain Function and Disorders MOE Frontiers Center for Brain Science Shanghai 201203 China

S

Shuo Geng

Virginia Tech, Blacksburg, Virginia, United States

Y

Yuchen Liu

T

Tao Sun

C

Chen Jiang